BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 31243334)

  • 1. Assessing the interactions between radiotherapy and antitumour immunity.
    Grassberger C; Ellsworth SG; Wilks MQ; Keane FK; Loeffler JS
    Nat Rev Clin Oncol; 2019 Dec; 16(12):729-745. PubMed ID: 31243334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining radiotherapy and cancer immunotherapy: a paradigm shift.
    Formenti SC; Demaria S
    J Natl Cancer Inst; 2013 Feb; 105(4):256-65. PubMed ID: 23291374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Precision medicine and immuno-radiotherapy].
    Chargari C; Robert C; Genestie C; Deutsch E
    Cancer Radiother; 2021 Oct; 25(6-7):570-575. PubMed ID: 34391650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abscopal effect: Myth or reality?].
    Mirjolet C; Truc G
    Cancer Radiother; 2021 Oct; 25(6-7):533-536. PubMed ID: 34462213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
    Chajon E; Castelli J; Marsiglia H; De Crevoisier R
    Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adapting conventional cancer treatment for immunotherapy.
    Qiao J; Liu Z; Fu YX
    J Mol Med (Berl); 2016 May; 94(5):489-95. PubMed ID: 26910191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy.
    Serre R; Benzekry S; Padovani L; Meille C; André N; Ciccolini J; Barlesi F; Muracciole X; Barbolosi D
    Cancer Res; 2016 Sep; 76(17):4931-40. PubMed ID: 27302167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Combinatorial Approaches to Enhance Anti-tumor Immunity: Focus on Immune Checkpoint Blockade Therapy.
    Andersson P; Ostheimer C
    Front Immunol; 2019; 10():2083. PubMed ID: 31555290
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
    Lee L; Matulonis U
    Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological aspects of local radiotherapy: clinical relevance.
    Formenti SC
    Discov Med; 2010 Feb; 9(45):119-24. PubMed ID: 20193637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
    Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
    Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunotherapy for the treatment of head and neck cancer.
    Karam SD; Raben D
    Lancet Oncol; 2019 Aug; 20(8):e404-e416. PubMed ID: 31364593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation and immunotherapy: From concept to the clinic.
    Salama AK; Postow MA; Salama JK
    Cancer; 2016 Jun; 122(11):1659-71. PubMed ID: 26914620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future.
    Naghavi AO; Johnstone PA; Kim S
    Curr Probl Cancer; 2016; 40(1):38-67. PubMed ID: 26656977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.
    D'Andrea MA; Reddy GK
    Am J Clin Oncol; 2020 Mar; 43(3):218-228. PubMed ID: 31842114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?
    Wirsdörfer F; de Leve S; Jendrossek V
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Rancoule C; Vallard A; Jmour O; Vial N; Guillaume E; Guy JB; Magné N
    Bull Cancer; 2018 Dec; 105 Suppl 1():S92-S100. PubMed ID: 30595203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awakening the immune system with radiation: Optimal dose and fractionation.
    Gandhi SJ; Minn AJ; Vonderheide RH; Wherry EJ; Hahn SM; Maity A
    Cancer Lett; 2015 Nov; 368(2):185-90. PubMed ID: 25799953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.